Overview

Detailed Summary

Innovassynth Technologies is an integrated chemical company providing Life Sciences & Nucleosides, Specialty Chemicals and CRDMO (Contract Research, Development & Manufacturing) services from a multi-plant manufacturing campus near Khopoli, India, serving over 100 global customers with an export-led business model focused on the US and EU markets.
Financially, Q3 FY26 revenue was INR 22 Crore with YTD FY26 revenue of INR 52 Crore, but the company reported operating losses (EBITDA loss of INR 4.5 Cr in Q3 and YTD EBITDA loss INR 31 Cr) and PAT losses, reflecting weak near-term profitability despite a substantial order book and product commercialization pipeline.
Operationally, Innovassynth operates 9 multipurpose plants on a 60+ acre campus, supported by 50+ scientists including 10+ PhDs, and emphasizes backward integration and process improvements to enhance yields; these capabilities position the company to scale CRDMO and specialty life science manufacturing when order conversion accelerates.
Geography shifts are notable: export concentration remains high but regional mix changed materially in YTD FY26 from the prior year with USA share falling to 39% and EU rising to 35%, while ROW contributes 26%, indicating customer and revenue diversification that could reduce single-market concentration risk.
Sustainability credentials include consecutive Ecovadis Gold ratings and initiation of SBTi in 2026, while quality systems are robust (ISO 27001, 14001, 45001, 9001), signaling management’s intent to align manufacturing, compliance and ESG commitments with international customer expectations and tender eligibility.

Sector: Finance
Industry: Investment Company
Market Cap: 1,249 Cr
Volatility: Low Risk
P/E Ratio: -261.9
Industry P/E: 19.0
PEG Ratio: —
P/B Ratio: 8.5
52W High: 134.55
52W Low: 45.01

Sales CAGR

1Y: —
3Y: —
5Y: —
10Y: —

Profit CAGR

1Y: -458.33%
3Y: —
5Y: —
10Y: —

ROE

TTM: -15.71%
3Y: -2.25%
5Y: -2.21%
10Y: -2.11%

ROCE

TTM: -12.27%
3Y: -1.31%
5Y: -1.27%
10Y: -1.32%

Technicals

‌

Forecasts

Peers

Financial Services Financial Services Finance Investment Company

Symbol	Watchlist	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
PNBGILTS		85.45	1,537 Cr	15.03	0.90	2.34	10.62	5.84	0.38
INOVSYNTH		134.55	1,249 Cr	-261.94	8.48	0.00	-15.71	-12.27	-12.77
VHL		3503.30	1,118 Cr	5.17	0.30	0.14	5.74	6.09	5.73
INDPRUD		6588.00	1,104 Cr	17.32	1.30	1.83	7.50	7.51	7.24
JPOLYINVST		1044.00	1,097 Cr	1.28	0.68	0.00	53.43	61.92	47.91
JINDALPHOT		1060.30	1,071 Cr	-47.00	1.05	0.00	-2.23	-1.34	-1.83
STEL		560.75	1,035 Cr	51.51	0.64	0.00	1.23	1.66	1.17
Median: 7 Co.	—	1044.00	1,104 Cr	5.17	0.90	0.00	5.74	5.84	1.17

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

Ask AI

Consolidated Quarterly Results (in ₹ Crores)

View Standalone

Total Figures

QoQ Changes

Total Figures

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Sales	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Expenses	0.10	0.08	0.08	0.09	0.09	0.12	0.12	0.09	0.11	0.13
Operating Profit	-0.18	-0.17	-0.17	-0.21	-0.18	-0.22	-0.23	-0.20	-0.22	-0.25
OPM %	—	—	—	—	—	—	—	—	—	—
Other Income	-4.88	-1.11	-3.67	9.52	-5.69	-5.50	3.43	4.18	-6.78	-4.68
Interest	0.08	0.09	0.09	0.12	0.09	0.10	0.11	0.11	0.11	0.12
Depreciation	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Profit Before Tax	-5.07	-1.29	-3.84	9.31	-5.86	-5.72	3.19	3.98	-7.00	-4.94
Tax %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit	-5.07	-1.29	-3.84	9.31	-5.86	-5.72	3.19	3.98	-7.00	-4.94
EPS in Rs	-0.55	-0.14	-0.41	1.00	-0.63	-0.74	0.34	0.43	0.75	-0.53

Consolidated Profit Loss (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	0.00	0.00	0.00	0.00	0.00
Expenses	0.37	0.37	0.35	0.42	0.44
Operating Profit	-0.65	-0.68	-0.70	-0.82	-0.87
OPM %	—	—	—	—	—
Other Income	1.86	-0.90	-0.15	-3.53	-4.67
Interest	0.27	0.30	0.34	0.40	0.43
Depreciation	0.00	0.00	0.00	0.00	0.00
Profit Before Tax	1.22	-1.58	-0.84	-4.35	-5.55
Tax %	0.00	0.00	0.00	0.00	0.00
Net Profit	1.22	-1.58	-0.84	-4.69	-5.55
EPS in Rs	0.13	-0.17	-0.10	-0.60	0.99
Dividend Payout %	0.00	0.00	0.00	0.00	—

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	24	24	24	28
Reserves	13	13	12	14
Borrowings	2.85	3.24	3.59	4.40
Other Liabilities	0.94	1.22	1.56	1.96
Total Liabilities	41	41	41	49
Fixed Assets	0.00	0.00	0.00	0.00
CWIP	0.00	0.00	0.00	0.00
Investments	41	41	41	49
Other Assets	0.01	0.02	0.01	0.07
Total Assets	41	41	41	49

Consolidated Cash Flows (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	-0.32	-0.34	-0.33	-0.73
Cash from Investing Activity	0.00	0.00	0.00	0.00
Cash from Financing Activity	0.32	0.36	0.32	0.77
Net Cash Flow	0.00	0.02	-0.01	0.04

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Jan 2026	Mar 2026	May 2026	Jun 2026
Promoters	36.26%	36.26%	31.46%	31.46%	31.46%	31.46%	31.46%	73.70%	73.70%	73.70%	75.04%	75.04%
FIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
DIIs	3.71%	3.71%	3.22%	3.94%	3.90%	3.90%	3.90%	2.84%	2.84%	2.84%	2.36%	2.25%
Public	60.02%	60.02%	65.32%	64.60%	64.64%	64.64%	64.64%	23.46%	23.46%	23.46%	22.60%	22.71%
Total Shareholders	27,194	26,991	26,882	27,308	27,157	27,117	27,086	26,957	26,908	26,898	27,337	27,084

Market Transactions

Unlock more with professional

Real-time bulk & block deal transactions
Export transaction data for analysis

Projection

Documents

Presentations

Concalls

Reports

Presentations

Investor Presentation

Q4 FY26

Investor Presentation

Q3 FY26

Actions

Action Type

‌
‌

Announcements

Last 7 days

Sentiment

Sorry, no results found!

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.